Non-Canonical Kinases and Substrates in Cancer Progression

by Francisco M. Vega
Published 2021-04-01

The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53.

by Alberto Valbuena, Sandra Blanco, Francisco M Vega, Pedro A Lazo
Published 2008-01-01

RhoB regulates cell migration through altered focal adhesion dynamics

by Francisco M. Vega, Audrey Colomba, Nicolas Reymond, Mairian Thomas, Anne J. Ridley
Published 2012-01-01

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95]

by Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Published 2020-03-01

CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours

by Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Published 2019-11-01

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma”

by Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal
Published 2020-03-01

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation

by Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Aida Amador-Álvarez, Kai-Oliver Henrich, Diego Pascual-Vaca, Konstantin Okonechnikov, Eloy Rivas, Frank Westermann, Ricardo Pardal, Francisco M. Vega
Published 2020-11-01